A Study to Evaluate INCB177054 in Participants With Select Advanced or Metastatic Solid Tumors (clinicaltrials.gov) - Sep 2, 2026 - P1/2 | N=9 | Terminated | Sponsor: Incyte Corporation | Active, not recruiting ➔ Terminated; This was a strategic business decision. There were no safety concerns contributing to this decision.
Trial termination • Head and Neck Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • Squamous Cell Carcinoma of Head and Neck • CD4 • PD-L1
|